Parissenti AM, Pritzker LB, Dahle MA, Gythfeldt HVL, et al. High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy. Breast Cancer Res 2025;27:143.
PMID: 40790765